1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
(
- Contribution to journal › Article
- 2019
-
Mark
Simvastatin downregulates adipogenesis in 3T3-l1 preadipocytes and orbital fibroblasts from graves’ ophthalmopathy patients
(
- Contribution to journal › Article
- 2014
-
Mark
Statin use and risk of depression: a Swedish national cohort study
(
- Contribution to journal › Article
- 2013
-
Mark
Simvastatin decreases the level of heparin-binding protein in patients with acute lung injury
(
- Contribution to journal › Article
- 2010
-
Mark
Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus
(
- Contribution to journal › Article
- 2006
-
Mark
Simvastatin maintains steady patterns of GFR and improves AER and expression of slit diaphragm proteins in type II diabetes
(
- Contribution to journal › Article
- 2003
-
Mark
A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: The treat-to-target (3T) study
(
- Contribution to journal › Article